Hypothyroidism in the Elderly: Who Should Be Treated and How?
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Hypothyroidism is among the most frequent chronic diseases in the elderly, and levothyroxine (l-T4) is worldwide within the 10 drugs more prescribed in the general population. Hypothyroidism is defined by increased serum thyroid-stimulating hormone (TSH) values and reduced circulating free thyroid hormones, whereas subclinical hypothyroidism (sHT) is characterized by free hormone fractions within the normal ranges and has been divided into two classes, depending on circulating TSH levels (above or below 10 mIU/L). Given that during aging, a natural trend toward higher values of circulating TSH has been reported, it is necessary to verify carefully the diagnosis of sHT to tailor an appropriate follow-up and ad hoc therapy, avoiding unnecessary or excessive treatment. In the current review, we evaluate the state of the art on hypothyroidism in the elderly with special focus on the effect of sHT on cognition and the cardiovascular system function. We also summarize the recommendations for a correct diagnostic workup and therapeutic approach to older people with an elevated TSH value, with special attention to the presence of frailty, comorbidities, and poly therapy. In conclusion, personalized therapy is crucial in good clinical practice, and in the management of older patients with sHT, multiple factors must be considered, including age-dependent TSH cutoffs, thyroid autoimmunity, the burden of comorbidities, and the possible presence of frailty. l-T4 is the drug of choice for the treatment of hypothyroid older people, but the risk of overtreatment, potential adverse drug reactions, and patient compliance should always be considered and thyroid status periodically reassessed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279 · cited 3×
“In the NHANES III study, 13,000 healthy subjects have been followed up and monitored by consecutive dosage of circulating FT3, FT4, TSH, TgAb, and TPOAb; among them, 10% resulted in TgAb and 11% in TPOAb positive [11].”
BackgroundInfluentialThe Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928 · cited 6×
“Drugs interfering with L-T4 absorption are also a frequent cause of hypothyroidism, despite proper replacement therapy, especially in the elderly [19].”
BackgroundInfluentialGarber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
Global epidemiology of hyperthyroidism and hypothyroidism
Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., & Okosieme, O. E. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.18 · Cited by 1,552
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418 · cited 2×
“Subclinical hypothyroidism (sHT) is characterized by increased TSH values in the face of circulating FT3 and FT4 values within the normal range [3].”
BackgroundCooper, D. S., & Biondi, B. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60276-6 · Cited by 1,039 · cited 2×
“However, the effects and the clinical significance of sHT on the cardiovascular system are still under debate; they are usually recognized in young adults, whereas more conflicting results have been obtained in the elderly [4, 13, 46, 47].”
BackgroundResult2013 ETA Guideline: Management of Subclinical Hypothyroidism
Pearce, S. H. S., Brabant, G., Duntas, L. H., Monzani, F., Peeters, R. P., Razvi, S., & Wemeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000356507 · Cited by 877
Self-citationAndersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686
Fade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567 · cited 1×
“60 years in the same geographic area [16].”
BackgroundGencer, B., Collet, T.-H., Virgini, V., Bauer, D. C., Gussekloo, J., Cappola, A. R., Nanchen, D., den Elzen, W. P. J., Balmer, P., Luben, R. N., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.096024 · Cited by 517
Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism
Stott, D. J., Rodondi, N., Kearney, P. M., Ford, I., Westendorp, R. G. J., Mooijaart, S. P., Sattar, N., Aubert, C. E., Aujesky, D., Bauer, D. C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1603825 · Cited by 490 · cited 3×
“Finally, the circulating antithyroid autoantibody titer was not assessed, and antibody-positive patients aremore likely to have progressive hypothyroidism; therefore, theymay bemore likely to have a benefit from long-term L-T4 therapy [47, 60].”
BackgroundResultMARIOTTI, S., FRANCESCHI, C., COSSARIZZA, A., & PINCHERA, N. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-6-686 · Cited by 449
2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism
Wiersinga, W. M., Duntas, L., Fadeyev, V., Nygaard, B., & Vanderpump, M. P. J. (2012) · European Thyroid Journal · doi:10.1159/000339444 · Cited by 437 · cited 2×
“Accordingly, the 2012 European Thyroid Association guidelines suggest that the combined therapy T4/T3 should be used only in patients with normal TSH values reached with L-T4 alone, but with persistent complaints, and only after having educated patients about the chronic nature of their disease [68].”
BackgroundAge-Related Changes in Thyroid Function: A Longitudinal Study of a Community-Based Cohort
Bremner, A. P., Feddema, P., Leedman, P. J., Brown, S. J., Beilby, J. P., Lim, E. M., Wilson, S. G., O'Leary, P. C., & Walsh, J. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3020 · Cited by 336 · cited 2×
“Indeed, a large, prospective cohort study on 3233 subjects older than 65 years did not show any relationship between cardiovascular disorders and sHT, apart from an association with the development of atrial fibrillation [43].”
BackgroundGrozinsky-Glasberg, S., Fraser, A., Nahshoni, E., Weizman, A., & Leibovici, L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0448 · Cited by 296 · cited 1×
“depression, fatigue, anxiety, cognitive performance, and QoL) did not find any difference between T4 + T3 and T4 in monotherapy [65].”
BackgroundThyroid Hormone Concentrations, Disease, Physical Function, and Mortality in Elderly Men
van den Beld, A. W., Visser, T. J., Feelders, R. A., Grobbee, D. E., & Lamberts, S. W. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0872 · Cited by 294 · cited 2×
“Indeed, the low T3 syndrome is associated with reduced physical function and worse prognosis, both quoad vitam and quoad valetudinem [28, 37].”
BackgroundExtreme Longevity Is Associated with Increased Serum Thyrotropin
Atzmon, G., Barzilai, N., Hollowell, J. G., Surks, M. I., & Gabriely, I. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2325 · Cited by 260 · cited 1×
“Moreover, several huge cohort studies have demonstrated that the distribution of serumTSH levels shows a tendency to increase in relation to the age and that the extreme longevity is associated with a further increase of TSH levels, at least in the Ashkenazy population [40, 41].”
BackgroundAn approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits
Boucai, L., Hollowell, J. G., & Surks, M. I. (2011) · Thyroid · doi:10.1089/thy.2010.0092 · Cited by 235
Complex alteration of thyroid function in healthy centenarians.
Mariotti, S., Barbesino, G., Caturegli, P., Bartalena, L., Sansoni, P., Fagnoni, F., Monti, D., Fagiolo, U., Franceschi, C., & Pinchera, A. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.5.8077303 · Cited by 234 · cited 1×
“75 to 80 years of age and in centenarians [26, 33].”
BackgroundThyroid Function and the Risk of Alzheimer Disease<subtitle>The Framingham Study</subtitle>
Tan, Z. S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.14.1514 · Cited by 225
Nanchen, D., Gussekloo, J., Westendorp, R. G. J., Stott, D. J., Jukema, J. W., Trompet, S., Ford, I., Welsh, P., Sattar, N., Macfarlane, P. W., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1978 · Cited by 211
Familial Longevity Is Associated with Decreased Thyroid Function
Rozing, M. P., Houwing-Duistermaat, J. J., Slagboom, P. E., Beekman, M., Frölich, M., de Craen, A. J. M., Westendorp, R. G. J., & van Heemst, D. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0875 · Cited by 132 · cited 1×
“In particular, the offspring of 90-year-old subjects showed reduced FT3 circulating values and a better metabolic profile compared with their partners with less long-lived parents [31].”
BackgroundThyroid Hormones, Dementia, and Atrophy of the Medial Temporal Lobe
de Jong, F. J., den Heijer, T., Visser, T. J., de Rijke, Y. B., Drexhage, H. A., Hofman, A., & Breteler, M. M. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0449 · Cited by 129 · cited 1×
“In a longitudinal study conducted on a population of 1077 elderly subjects (aged 60 to 90 years), cognitively normal, no association was identified between TSH or thyroid hormones and hippocampal atrophy or risk of developing AD [52].”
BackgroundThyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism
Chao, M., Jiawei, X., Xia, H., Guoming, W., Yangang, W., Xufu, W., & Shuyao, Z. (2009) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32832c79e0 · Cited by 93
Aubert, C. E., Bauer, D. C., da Costa, B. R., Feller, M., Rieben, C., Simonsick, E. M., Yaffe, K., Rodondi, N., & Study, T. H. A. (2017) · Clinical Endocrinology · doi:10.1111/cen.13458 · Cited by 87
Karmisholt, J., Andersen, S., & Laurberg, P. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1021 · Cited by 86 · cited 1×
“However, when the presence of serum-positive TPOAb titers has been demonstrated, repeated measurements do not add much useful information in the monitoring of individual patients, as levels of TPOAb vary in parallel with TSH [23].”
BackgroundIs subclinical hypothyroidism a cardiovascular risk factor in the elderly?
Pasqualetti, G., Tognini, S., Polini, A., Caraccio, N., & Monzani, F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3818 · Cited by 79
Self-citationLiothyronine use in a 17 year observational population‐based study ‐ the tears study
Leese, G. P., Soto‐Pedre, E., & Donnelly, L. A. (2016) · Clinical Endocrinology · doi:10.1111/cen.13052 · Cited by 75 · cited 1×
“The outcomes in terms of cardiovascular events, diabetes, fractures, atrial fibrillation, or death were comparable; the only difference was an increased use of antipsychotic drugs in the combined therapy population, presumably as a result of the use of T3 [67].”
ResultVirili, C., Giovanella, L., Fallahi, P., Antonelli, A., Santaguida, M. G., Centanni, M., & Trimboli, P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00010 · Cited by 61 · cited 3×
“, gastric atrophy, Helicobacter pylori infection, lactose intolerance, or celiac disease), and/or the concomitant intake of drugs or food [62].”
BackgroundInfluentialHennessey, J. V., & Espaillat, R. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13062 · Cited by 49
Cited by
European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
Pasquali, R., Casanueva, F., Haluzik, M., van Hulsteijn, L., Ledoux, S., Monteiro, M. P., Salvador, J., Santini, F., Toplak, H., & Dekkers, O. M. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0893 · Cited by 188
Overt and Subclinical Hypothyroidism in the Elderly: When to Treat
Calsolaro, V., Niccolai, F., Pasqualetti, G., Calabrese, A. M., Polini, A., Okoye, C., Magno, S., Caraccio, N., & Monzani, F. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00177 · Cited by 68
Levothyroxine therapy in elderly patients with hypothyroidism
Effraimidis, G., Watt, T., & Feldt-Rasmussen, U. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.641560 · Cited by 60
“This is particularly the case in patients with a pre-existing heart failure, which should always be considered a possibility in the evaluation of older patients with hypothyroidism (48, 49).”
Background
Metadata
- Authors
- Calsolaro, V., Niccolai, F., Pasqualetti, G., Tognini, S., Magno, S., Riccioni, T., Bottari, M., Caraccio, N., & Monzani, F.
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2018-11-19
- Volume
- 3
- Issue
- 1
- Pages
- 146-158
- ISSN
- 2472-1972 (ISSN-L)
- OpenAlex
- W2900463442
- Cited by
- 47
- References
- 31
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.